How does a biotech balance great science with IP security to tell their story? Find out on today's episode of the Few & Far Between podcast!
Host Chris O'Brien welcomes Joshua Kresh, Emily Michiko Morris, and Mark Schultz from IPPI: The Intellectual Property Policy Institute. Tune in for a fascinating discussion on the dos and don'ts of IP protection.
Listen to the latest episode today!
"The history of rare disease drug development indicates that once you start looking harder for cases, you often tend to find them." - Will...
"I learned very early on that the stupidest cancer cell was cleverer than the cleverest oncologist." - Justin Stebbing, Editor-in-Chief of Oncogene, previously the...
How does a biopharma background prepare you for the biotech playground? Find out in our latest episode of the Biorasi Few & Far Between...